




Preparing video
Cochlear's (ASX: COH) full year sales increased 4% to $2.35B - with strong growth in Cochelar and aucoustic implants - offset by a decline in services revenue. Gross margins declined one percentage point. Operating expenses climbed 5%. Underlying profit grew by 1%; statutory net profit by 9% to $389 million. Shareholders will see a final dividend dividend of $2.15 per share. Looking ahead it is targeting a 11-17% lift in underlying net profit in FY26 - to between $435 and $460 million dollars...supported by the recent launch of its new Nucleus Nexa System in the US. Cochelar plans to invest around 13% of sales revenue in R&D with capacity expansion to drive oprational expenses. Cochlear has also approved a $75 million share buyback.
Amcor (ASX: AMC) has reported a net sales of around US$5 billion for the fourth quarter - up 43% from previous quarter...The packaging giant completed its acquisition of Berry Global expanding its portfolio which is expected to deliver US$650 million by 2028..It will provide an annual dividend of US51 cents per share. NYSE listed shares fell 12% overnight with investors seemingly disappointed with the result.
Mirvac (ASX: MGR) returned to profit in the past financial year with a statutory profit of $68M...even as full-year revenue fell 10% to $2.74 billion. This follows a loss of $805 million the previous year. Mirvac will deliver a final distribution of 4.5 cents per share, the same as in the first half, bringing its total distribution to 9¢.
Baby Bunting (ASX: BBN) is planning more store refurbishments after posting record full year sales. Profit rose 28% to $12.2 million -- coming in at the top end of its range. Baby Bunting is planning 10 to 12 “store of the future” refurbishments in FY26, alongside five new large-format outlets and three to five small-format pilot stores. The retailer says sales are up 4.8% in the first six weeks of the new financial year - driven by strong momentum in its New Zealand network. Baby Bunting is guiding to FY26 pro forma NPAT of $17 to $20 million.
HealthCo REIT (ASX: HCW) delivered funds from operations of $36.5 million dollars - Or 6.6 cents per unit. It will pay a full year distribution of 4.2 cent per share. All 11 hospitals owned by HCW and the Unlisted Healthcare Fund contniue to operate as normal - with the groups working with the receiver in relation to the Healthscope sale process. MD Sid Sharma says the REIT's conviction in private hospitals as an asset class remains unchanged. It expects to resume distributions once the Healthscope situation has been resolved.